Yuichiro Yano1, Jeremiah Stamler1, Daniel B Garside2, Martha L Daviglus2, Stanley S Franklin3, Mercedes R Carnethon1, Kiang Liu1, Philip Greenland1, Donald M Lloyd-Jones4. 1. Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois. 2. Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Institute for Minority Health Research, University of Illinois at Chicago, Chicago, Illinois. 3. Heart Disease Prevention Program, Department of Medicine, University of California, Irvine, Irvine, California. 4. Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: dlj@northwestern.edu.
Abstract
BACKGROUND: Isolated systolic hypertension (ISH), defined as systolic blood pressure (SBP) ≥140 mm Hg and diastolic blood pressure (DBP) <90 mm Hg, in younger and middle-aged adults is increasing in prevalence. OBJECTIVE: The aim of this study was to assess the risk for cardiovascular disease (CVD) with ISH in younger and middle-aged adults. METHODS: CVD risks were explored in 15,868 men and 11,213 women 18 to 49 years of age (mean age 34 years) at baseline, 85% non-Hispanic white, free of coronary heart disease (CHD) and antihypertensive therapy, from the Chicago Heart Association Detection Project in Industry study. Participant classifications were as follows: 1) optimal-normal blood pressure (BP) (SBP <130 mm Hg and DBP <85 mm Hg); 2) high-normal BP (130 to 139/85 to 89 mm Hg); 3) ISH; 4) isolated diastolic hypertension (SBP <140 mm Hg and DBP ≥90 mm Hg); and 5) systolic diastolic hypertension (SBP ≥140 mm Hg and DBP ≥90 mm Hg). RESULTS: During a 31-year average follow-up period (842,600 person-years), there were 1,728 deaths from CVD, 1,168 from CHD, and 223 from stroke. Cox proportional hazards models were adjusted for age, race, education, body mass index, current smoking, total cholesterol, and diabetes. In men, with optimal-normal BP as the reference stratum, hazard ratios for CVD and CHD mortality risk for those with ISH were 1.23 (95% confidence interval [CI]: 1.03 to 1.46) and 1.28 (95% CI: 1.04 to 1.58), respectively. ISH risks were similar to those with high-normal BP and less than those associated with isolated diastolic hypertension and systolic diastolic hypertension. In women with ISH, hazard ratios for CVD and CHD mortality risk were 1.55 (95% CI: 1.18 to 2.05) and 2.12 (95% CI: 1.49 to 3.01), respectively. ISH risks were higher than in those with high-normal BP or isolated diastolic hypertension and less than those associated with systolic diastolic hypertension. CONCLUSIONS: Over long-term follow-up, younger and middle-aged adults with ISH had higher relative risk for CVD and CHD mortality than those with optimal-normal BP.
BACKGROUND: Isolated systolic hypertension (ISH), defined as systolic blood pressure (SBP) ≥140 mm Hg and diastolic blood pressure (DBP) <90 mm Hg, in younger and middle-aged adults is increasing in prevalence. OBJECTIVE: The aim of this study was to assess the risk for cardiovascular disease (CVD) with ISH in younger and middle-aged adults. METHODS: CVD risks were explored in 15,868 men and 11,213 women 18 to 49 years of age (mean age 34 years) at baseline, 85% non-Hispanic white, free of coronary heart disease (CHD) and antihypertensive therapy, from the Chicago Heart Association Detection Project in Industry study. Participant classifications were as follows: 1) optimal-normal blood pressure (BP) (SBP <130 mm Hg and DBP <85 mm Hg); 2) high-normal BP (130 to 139/85 to 89 mm Hg); 3) ISH; 4) isolated diastolic hypertension (SBP <140 mm Hg and DBP ≥90 mm Hg); and 5) systolic diastolic hypertension (SBP ≥140 mm Hg and DBP ≥90 mm Hg). RESULTS: During a 31-year average follow-up period (842,600 person-years), there were 1,728 deaths from CVD, 1,168 from CHD, and 223 from stroke. Cox proportional hazards models were adjusted for age, race, education, body mass index, current smoking, total cholesterol, and diabetes. In men, with optimal-normal BP as the reference stratum, hazard ratios for CVD and CHD mortality risk for those with ISH were 1.23 (95% confidence interval [CI]: 1.03 to 1.46) and 1.28 (95% CI: 1.04 to 1.58), respectively. ISH risks were similar to those with high-normal BP and less than those associated with isolated diastolic hypertension and systolic diastolic hypertension. In women with ISH, hazard ratios for CVD and CHD mortality risk were 1.55 (95% CI: 1.18 to 2.05) and 2.12 (95% CI: 1.49 to 3.01), respectively. ISH risks were higher than in those with high-normal BP or isolated diastolic hypertension and less than those associated with systolic diastolic hypertension. CONCLUSIONS: Over long-term follow-up, younger and middle-aged adults with ISH had higher relative risk for CVD and CHD mortality than those with optimal-normal BP.
Authors: Timo E Strandberg; Veikko V Salomaa; Hannu T Vanhanen; Kaisu Pitkälä; Tatu A Miettinen Journal: J Hypertens Date: 2002-03 Impact factor: 4.844
Authors: Carmel M McEniery; John R Cockcroft; Mary J Roman; Stanley S Franklin; Ian B Wilkinson Journal: Eur Heart J Date: 2014-01-23 Impact factor: 29.983
Authors: Yuichiro Yano; Jared P Reis; Laura A Colangelo; Daichi Shimbo; Anthony J Viera; Norrina B Allen; Samuel S Gidding; Adam P Bress; Philip Greenland; Paul Muntner; Donald M Lloyd-Jones Journal: JAMA Date: 2018-11-06 Impact factor: 56.272
Authors: John W McEvoy; Nilanjan Chatterjee; Brian P McGrath; Prosenjit Kundu; Natalie Daya; Josef Coresh; Elizabeth Selvin Journal: Hypertension Date: 2020-07-27 Impact factor: 10.190
Authors: Yuichiro Yano; Ian J Neeland; Colby Ayers; Ronald Peshock; Jarett D Berry; Donald M Lloyd-Jones; Philip Greenland; Gary F Mitchell; Wanpen Vongpatanasin Journal: Hypertension Date: 2017-05-15 Impact factor: 10.190
Authors: Seamus P Whelton; John W McEvoy; Leslee Shaw; Bruce M Psaty; Joao A C Lima; Matthew Budoff; Khurram Nasir; Moyses Szklo; Roger S Blumenthal; Michael J Blaha Journal: JAMA Cardiol Date: 2020-09-01 Impact factor: 14.676
Authors: Maleesa M Pathirana; Zohra S Lassi; Anna Ali; Margaret A Arstall; Claire T Roberts; Prabha H Andraweera Journal: Endocrine Date: 2020-09-15 Impact factor: 3.633
Authors: Wilby Williamson; Adam J Lewandowski; Nils D Forkert; Ludovica Griffanti; Thomas W Okell; Jill Betts; Henry Boardman; Timo Siepmann; David McKean; Odaro Huckstep; Jane M Francis; Stefan Neubauer; Renzo Phellan; Mark Jenkinson; Aiden Doherty; Helen Dawes; Eleni Frangou; Christina Malamateniou; Charlie Foster; Paul Leeson Journal: JAMA Date: 2018-08-21 Impact factor: 56.272